Limbus Contour

By Limbus AI
· Canada
Limbus AI — Automated contouring for radiotherapy planning.
Workflow Optimization
Radiation Oncology
Production
FDA Cleared
Regulatory status
FDA Cleared
Deployment
Production
Clinical role
Adjunct (decision support)
Headquarters
Canada
AI type
Workflow Optimization

Precise indication

Automated contouring for radiotherapy planning.

Regulatory status

At least three distinct FDA 510(k) clearances identified (K201232, K230575, K241837).

Clinical evidence

Vendor-supported

Not the primary source used here.

Independent

Independent validation study (Frontiers in Oncology) comparing AI contouring against multiple radiation oncologists; also presented via an NHS AI Fellowship implementation poster.

Real-world deployment

Documented clinical implementation interest via the NHS AI Fellowship program.

Interoperability

European status

Editorial verdict

Limits and uncertainties

Read the full Frontiers in Oncology study before publishing to extract exact concordance/agreement figures.

Sources

https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1089807/full

This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate

At a glance
Vendor
Limbus AI
Headquarters
Canada
AI type
Workflow Optimization
Specialty
Clinical role
Adjunct (decision support)
CE marking
Notified body
EU AI Act
Data hosting
Last verified
Reviewed by
How we evaluate

Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.

A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.

Read the methodology →

Spotted an error?

Vendors, authors and clinicians can request a correction. Corrections are dated on the profile.